Nineteenth Annual Pezcoller Symposium: Hypothesis-driven clinical investigation in cancer Journal Article


Authors: Kaelin, W. G.; Sawyers, C. L.; Mihich, E.
Article Title: Nineteenth Annual Pezcoller Symposium: Hypothesis-driven clinical investigation in cancer
Abstract: This symposium was held in Trento, Italy, from June 14 to 16, 2007, and was cochaired by William G. Kaelin, Enrico Mihich, and Charles L. Sawyers. A session was deveted to the proof of concept derived from successes in target-oriented therapeutics. Molecular targets must be identified in each patients because they are equally present in all patients with the same tumor type. A session was devoted to the identification of markers of drug effectiveness. Two sessions were focused on opportunities for developing new specific molecular target-oriented therapies. ©2007 American Association for Cancer Research.
Keywords: cancer survival; gene mutation; erlotinib; drug efficacy; nonhuman; clinical trials as topic; conference paper; neoplasms; cell proliferation; animals; imatinib; dasatinib; chronic myeloid leukemia; drug design; cancer research; oncogene; glioblastoma; fluorodeoxyglucose f 18; gefitinib; cancer relapse; down regulation; drugs, investigational; drug sensitivity; gallium 68
Journal Title: Cancer Research
Volume: 67
Issue: 23
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2007-12-01
Start Page: 11102
End Page: 11105
Language: English
DOI: 10.1158/0008-5472.can-07-3230
PUBMED: 18045966
PROVIDER: scopus
DOI/URL:
Notes: --- - "Export Date: 17 November 2011" - "CODEN: CNREA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Charles L Sawyers
    225 Sawyers